These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18521104)

  • 1. Emperipolesis, entosis and beyond: dance with fate.
    Xia P; Wang S; Guo Z; Yao X
    Cell Res; 2008 Jul; 18(7):705-7. PubMed ID: 18521104
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural killer cells go inside: entosis versus cannibalism.
    Qian Y; Shi Y
    Cell Res; 2009 Dec; 19(12):1320-1. PubMed ID: 19956185
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress of research in cell-in-cell phenomena.
    Yang YQ; Li JC
    Anat Rec (Hoboken); 2012 Mar; 295(3):372-7. PubMed ID: 22271432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avian NK activities, cells and receptors.
    Rogers SL; Viertlboeck BC; Göbel TW; Kaufman J
    Semin Immunol; 2008 Dec; 20(6):353-60. PubMed ID: 18948017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells in innate immunity and cancer.
    Becknell B; Caligiuri MA
    J Immunother; 2008 Oct; 31(8):685-92. PubMed ID: 18779751
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation.
    Raemer PC; Kohl K; Watzl C
    Eur J Immunol; 2009 Jun; 39(6):1456-65. PubMed ID: 19424968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of phototherapy on the numbers of circulating natural killer cells and T lymphocytes in psoriasis.
    Tobin AM; Maguire B; Enright H; Kirby B
    Photodermatol Photoimmunol Photomed; 2009 Apr; 25(2):109-10. PubMed ID: 19292789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invariant natural killer T cells and immunotherapy of cancer.
    Molling JW; Moreno M; van der Vliet HJ; van den Eertwegh AJ; Scheper RJ; von Blomberg BM; Bontkes HJ
    Clin Immunol; 2008 Nov; 129(2):182-94. PubMed ID: 18783990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killer dendritic cells: IKDC and the others.
    Bonmort M; Dalod M; Mignot G; Ullrich E; Chaput N; Zitvogel L
    Curr Opin Immunol; 2008 Oct; 20(5):558-65. PubMed ID: 18554881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of Cell-in-Cell Structures: Different Phenomena with Similar Appearance.
    Borensztejn K; Tyrna P; Gaweł AM; Dziuba I; Wojcik C; Bialy LP; Mlynarczuk-Bialy I
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of peripheral blood natural killer cells.
    Perussia B; Loza MJ
    Methods Mol Med; 2005; 107():147-61. PubMed ID: 15492370
    [No Abstract]   [Full Text] [Related]  

  • 12. Notch increases T/NK potential of human hematopoietic progenitors and inhibits B cell differentiation at a pro-B stage.
    Benne C; Lelievre JD; Balbo M; Henry A; Sakano S; Levy Y
    Stem Cells; 2009 Jul; 27(7):1676-85. PubMed ID: 19544442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
    Sutlu T; Alici E
    J Intern Med; 2009 Aug; 266(2):154-81. PubMed ID: 19614820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanisms of tumor and immune system interaction].
    Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS
    Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839
    [No Abstract]   [Full Text] [Related]  

  • 16. Activated T cells inhibit NK cell-mediated tumour rejection.
    Wang XJ; Hu J; Yuan J; Peng YM; Gui L; He WF; Tan J; Luo GX; Wu J
    Scand J Immunol; 2009 Apr; 69(4):337-41. PubMed ID: 19284498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal intraepithelial NK and NKT cell ontogeny in Lewis rats.
    Marín-Gallén S; Pérez-Cano FJ; Castell M; Castellote C; Franch A
    Dev Comp Immunol; 2008; 32(12):1405-8. PubMed ID: 18638501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killers and beyond: NK-cell-mediated control of immune responses.
    Andoniou CE; Coudert JD; Degli-Esposti MA
    Eur J Immunol; 2008 Nov; 38(11):2938-42. PubMed ID: 18979519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG; Placke T; Salih HR
    Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anesthetics and analgesics on natural killer cell activity.
    Welden B; Gates G; Mallari R; Garrett N
    AANA J; 2009 Aug; 77(4):287-92. PubMed ID: 19731847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.